EUR 22.9
(0.44%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 1.19 Billion EUR | -1.29% |
2022 | 1.21 Billion EUR | -7.08% |
2021 | 1.3 Billion EUR | 0.43% |
2020 | 1.3 Billion EUR | 27.05% |
2019 | 1.02 Billion EUR | 97.56% |
2018 | 518.42 Million EUR | -3.19% |
2017 | 535.48 Million EUR | 6.1% |
2016 | 504.71 Million EUR | -0.65% |
2015 | 508.01 Million EUR | 6.0% |
2014 | 479.23 Million EUR | 17.12% |
2013 | 409.16 Million EUR | 20.96% |
2012 | 338.26 Million EUR | 27.37% |
2011 | 265.56 Million EUR | 35.26% |
2010 | 196.34 Million EUR | 4.73% |
2009 | 187.47 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 1.22 Billion EUR | 0.0% |
2023 FY | 1.19 Billion EUR | -1.29% |
2023 Q4 | 1.19 Billion EUR | 0.0% |
2023 Q2 | 1.25 Billion EUR | 0.0% |
2022 Q2 | 1.25 Billion EUR | 0.0% |
2022 FY | 1.21 Billion EUR | -7.08% |
2022 Q4 | 1.21 Billion EUR | 0.0% |
2021 FY | 1.3 Billion EUR | 0.43% |
2021 Q4 | 1.3 Billion EUR | 0.0% |
2021 Q2 | 1.27 Billion EUR | 0.0% |
2020 Q4 | 1.3 Billion EUR | 0.0% |
2020 Q2 | 1.04 Billion EUR | 0.0% |
2020 FY | 1.3 Billion EUR | 27.05% |
2019 FY | 1.02 Billion EUR | 97.56% |
2019 Q2 | 1 Billion EUR | 0.0% |
2019 Q4 | 1.02 Billion EUR | 0.0% |
2018 FY | 518.42 Million EUR | -3.19% |
2018 Q4 | 518.42 Million EUR | 0.0% |
2018 Q2 | 509.11 Million EUR | 0.0% |
2017 Q2 | 537.61 Million EUR | 0.0% |
2017 FY | 535.48 Million EUR | 6.1% |
2017 Q4 | 535.48 Million EUR | 0.0% |
2016 Q4 | 504.71 Million EUR | 0.0% |
2016 FY | 504.71 Million EUR | -0.65% |
2016 Q2 | 528.07 Million EUR | 0.0% |
2015 FY | 508.01 Million EUR | 6.0% |
2015 Q2 | 449.68 Million EUR | 0.0% |
2015 Q4 | 508.01 Million EUR | 0.0% |
2014 Q2 | 437.39 Million EUR | 0.0% |
2014 FY | 479.23 Million EUR | 17.12% |
2014 Q4 | 479.23 Million EUR | 0.0% |
2013 Q4 | 409.16 Million EUR | 0.0% |
2013 FY | 409.16 Million EUR | 20.96% |
2013 Q2 | 364.69 Million EUR | 0.0% |
2012 Q2 | 278.07 Million EUR | 0.0% |
2012 Q4 | 338.26 Million EUR | 0.0% |
2012 FY | 338.26 Million EUR | 27.37% |
2011 Q4 | 265.56 Million EUR | 0.0% |
2011 Q2 | 236.47 Million EUR | 0.0% |
2011 FY | 265.56 Million EUR | 35.26% |
2010 FY | 196.34 Million EUR | 4.73% |
2010 Q4 | 196.34 Million EUR | 0.0% |
2009 FY | 187.47 Million EUR | 0.0% |
2009 Q4 | 187.47 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Cegedim SA | 629.51 Million EUR | -90.404% |
Guerbet SA | 646.97 Million EUR | -85.267% |
Nexus AG | 153.13 Million EUR | -682.726% |
Bastide Le Confort Médical SA | 566.34 Million EUR | -111.642% |
Revenio Group Oyj | 37.6 Million EUR | -3087.816% |
Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 35.109% |
Sartorius Aktiengesellschaft | 6.99 Billion EUR | 82.872% |
Siemens Healthineers AG | 28.55 Billion EUR | 95.802% |
Medios AG | 125.94 Million EUR | -851.693% |
Equasens Société anonyme | 166.41 Million EUR | -620.242% |
Stratec SE | 246.2 Million EUR | -386.838% |